Search
for

    Glossary Skindex-16

    dermatology questionnaire assessing skin condition impact on quality of life

    Skindex-16 is a dermatology-specific questionnaire designed to measure the impact of skin conditions on a patient's quality of life. It consists of 16 questions that assess symptoms, emotions, and functioning, providing valuable insights for both patients and healthcare professionals to evaluate the psychological and social effects of skin diseases like alopecia.

    Related Terms

    Sort by

    Research 30 of 210

    1. Arabic version of Skindex‐16: Translation and cultural adaptation, with assessment of reliability and validity International Journal of Dermatology · 2007 · 24 citations
    2. Validation of an Egyptian Arabic Version of Skindex-16 and Quality of Life Measurement in Egyptian Patients with Skin Disease International Journal of Behavioral Medicine · 2017 · 17 citations
    3. PCR30 PSYCHOMETRIC EVALUATION OF SKINDEX-16 AA, THE ALOPECIA AREATA SYMPTOM IMPACT SCALE (AASIS), AND THE SCALP HAIR ASSESSMENT PATIENT-REPORTED OUTCOME (PRO) IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA Value in Health · 2026
    4. Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia Journal of The American Academy of Dermatology · 2011 · 86 citations
    5. Clinician vs Self-ratings of Hirsutism in Patients With Polycystic Ovarian Syndrome JAMA dermatology · 2016 · 52 citations
    6. Scalp Hair Regrowth Is Associated With Improvements in Health-Related Quality of Life and Psychological Symptoms in Patients With Severe Alopecia Areata: Results From Two Randomized Controlled Trials SKIN The Journal of Cutaneous Medicine · 2023 · 4 citations
    7. Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · 2026
    8. 63532 Impact of Eyebrow and Eyelash Hair Loss on Health-Related Quality of Life Among Patients with Alopecia Areata: Results From a Real-World Survey in 5 European Countries Journal of the American Academy of Dermatology · 2025
    9. 0475 High-dose UVA-1 therapy improves patient-reported outcomes and clinical scores in patients with sclerosing skin disease Journal of Investigative Dermatology · 2025
    10. Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials JEADV Clinical Practice · 2023
    11. Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study Frontiers in Public Health · 2024
    12. Prevalence of Common Skin Diseases and Their Associated Factors among Military Personnel in Korea: A Cross-sectional Study Journal of Korean Medical Science · 2012 · 41 citations
    13. Evaluation of the dermatologic life quality among cleanroom workers in a secondary battery factory Annals of occupational and environmental medicine · 2016
    14. Health-Related Quality of Life, Depression, and Self-esteem in Patients With Androgenetic Alopecia JAMA Dermatology · 2021 · 15 citations
    15. Quality of life in patients with alopecia areata: a hospital‐based cross‐sectional study Journal of the European Academy of Dermatology and Venereology · 2015 · 25 citations
    16. A systematic review of patient‐reported outcomes in patients with cutaneous lupus erythematosus British Journal of Dermatology · 2016 · 18 citations
    17. TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris 2026
    18. SLAGANJE DVA INSTRUMENTA ZA OCENU KVALITETA ŽIVOTA U DERMATOLOGIJI Praxis medica · 2013
    19. The Impact of Androgenic Alopecia on the Quality of Life of Male Individuals: A Cross-Sectional Study Cureus · 2023
    20. withdrawn Journal of The American Academy of Dermatology · 2016
    21. Comparative efficacy of photodynamic therapy, autologous platelet-rich plasma therapy, and their combination in the treatment of diffuse telogen effluvium Russian Journal of Skin and Venereal Diseases · 2026
    22. Psychosocial and mental impact of alopecia areata: Analysis of the Danish Skin Cohort Journal of the European Academy of Dermatology and Venereology · 2024 · 17 citations
    23. A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes Journal of Clinical Medicine · 2025
    24. Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results Journal of the European Academy of Dermatology and Venereology · 2025
    25. The Polish version of Skindex-29: psychometric properties of an instrument to measure quality of life in dermatology Postepy Dermatologii I Alergologii · 2014 · 9 citations
    26. Effects of the RV3466F lotion on female telogen effluvium: Results from a 16 week, multi-centric, controlled, randomized trial Journal of The American Academy of Dermatology · 2019
    27. Quality of Life with Alopecia Areata versus Androgenetic Alopecia Assessed Using Hair Specific Skindex-29 Annals of Dermatology · 2018 · 13 citations
    28. Validation of a Cross-cultural Adaptation of the Hair Specific Skindex-29 Scale to Spanish Actas Dermo-Sifiliográficas · 2018
    29. Item-specific patterns of the Skindex-17 in individuals with different levels of Hidradenitis Suppurativa severity: a network analysis study Frontiers in Public Health · 2023 · 2 citations
    30. Qualidade de vida relacionada à saúde em homens e mulheres com alopecia androgenética em uso de terapia com luz de baixa intensidade 2020